Biotech

All Articles

Metsera join Amneal to secure down GLP-1 supply

.With very early phase 1 information right now out in bush, metabolic health condition ensemble Mets...

Rivus articles information to back up muscle-sparing being overweight drug insurance claims

.Rivus Pharmaceuticals has actually introduced the data behind its stage 2 being overweight win in c...

BMS pays for $110M to create T-cell treatment contract, aiding Main buy time to improve prioritized pipeline

.Bristol Myers Squibb is actually paying out Top Medication $110 million beforehand to develop reage...

Generate gains another $1B-plus Large Pharma relationship

.Novartis has actually inked a package potentially worth more than $1 billion with Flagship-founded ...

Metsera GLP-1 information piece exposes 7.5% fat burning at 36 times

.Just recently debuted Metsera is unfolding some stage 1 record for its GLP-1 receptor agonist, reve...

Flagship hopes biotechs group to Mirai to boost genetic meds

.In the middle of the genetic medications branches ethnicity, Crown jewel Pioneering is revealing a ...

BioAge eyes $180M from IPO, private positioning for obesity trials

.BioAge Labs is actually eyeing around $180 million in initial earnings coming from an IPO and also ...

Merck's LAG-3 combo falls short colon cancer stage 3 study

.A try by Merck &amp Co. to open the microsatellite secure (MSS) metastatic intestines cancer market...

Spanish VC closes $200M lifestyle scientific researches fund

.Spain-based Asabys Partners has actually closed a fund of 180 thousand europeans ($ 200 thousand), ...

BioAge brings in $198M from IPO as being overweight biotech participates in Nasdaq

.BioAge Labs is actually bringing in virtually $200 thousand through its own Nasdaq IPO today, with ...